Search

Research teams at the Max Delbrück Center and its partner institutions used almost 17,000 fewer research animals in 2023 than in the previous year. The Center has now submitted these figures to the Berlin State Office for Health and Social Affairs (LaGeSo).

The German Research Foundation (DFG) will fund single-cell scientist Simon Haas in its Heisenberg program. Therefore, the Berlin Institute of Health at Charité (BIH) is establishing a Heisenberg professorship in systems hematology. After five years, the BIH will make the professorship permanent.

At a workshop organized by EARA, researchers, animal welfare officers, and communicators gained insights into how they can communicate more openly and proactively about animal research. The event, with over 80 participants, was held in collaboration with the Max Delbrück Center.

On January 29th, the European Animal Research Association (EARA) and Charité –Universitätsmedizin Berlin, in collaboration with the Max Delbrück Center and Freie Universität Berlin, invite those working in the life science sector to discuss the need for greater transparency in animal research.

A tumor often arises when cancer genes multiply. In this process, additional genes act as hitchhikers, potentially creating previously unknown vulnerabilities that open the door to new therapeutic approaches. This finding is reported by a team led by ECRC-scientists Anton Henssen and Jan Dörr in "Cancer Discovery."

The European Molecular Biology Organization has selected Leif. S. Ludwig from the Berlin Institute of Health at Charité (BIH) and the Max Delbrück Center to become an EMBO Young Investigator. The program provides support to outstanding young life scientists.

Biomedical research is mostly geared towards white men. During the Berlin Science Week, researchers discussed how this can be changed and how questions of diversity can be better taken into account in laboratories. Didn't have time to join? We have documented the event for you as a video.

From 2024, the Federal Government and the State of Berlin will fund the establishment of the National Center for Tumor Diseases (NCT) Berlin. The new site is a cooperation between DKFZ and Charité, BIH, and Max Delbrück Center aimed at closely integrating clinical and translational cancer research.

Simon Haas has been awarded the Lisec-Artz Prize, endowed with €10,000, for his single-cell analysis of communication between stem and immune cells in blood cancer. The University of Bonn Foundation established this prize to honor outstanding early-career cancer researchers.

Swapping just a single amino acid can play a decisive role in transforming healthy B cells into cancer cells. An international team led by ECRC researcher Stephan Mathas describes in “Nature Communications” how a point mutation in the transcription factor IRF4 profoundly alters gene regulation.